EANM Executive Secretariat, Hollandstrasse 14 / Mezzanine, A-1020 Vienna, Austria
Phone: +43-(0)1-212 80 30, Fax: +43-(0)1-212 80 30-9, E-Mail: email@example.com
In 2008 the EANM published their paediatric dosage card. In 2011 the North American consensus guidelines recommended a set of administered activities for pediatric nuclear medicine. During the EANM congress in 2012 a working group of the EANM and the SNMMI met to study the possibilities to harmonize these guidelines. The purpose of this publication was to identify differences between these guidelines and suggest changes in both, in order to achieve a level of harmonizing.
In addition, the new version of the EANM paediatric dosage card (v 01.02.2014) was provided.
Dosage Card *
Dosage Card PDF in [MBq]
PedDoseIn addition to the dosage card, the PedDose App was developed and recently updated to the new, harmonized guideline. Available for Android and iPhone, the App was downloaded over 2,500 times on Google Play. Reviews by users rated it with 4.6 out of 5 stars.
Download: Android Version / iPhone Version (currently under maintenance)
Calculation of the administered activity in [MBq] and [mCi]
This card is based upon the publication by Jacobs F, Thierens H, Piepsz A, Bacher K, Van de Wiele C, Ham H, Dierckx RA. Optimized tracer-dependent dosage cards to obtain weightindependent effective doses. Eur J Nucl Med Mol Imaging. 2005 May; 32(5):581-8.
M. Lassmann, S.T.Treves. Pediatric Radiopharmaceutical Administration: Harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the 2010 North America Consensus guideline, Eur J Nucl Med Mol Imaging. 2014, DOI: 10.1007/s00259-014-2731-9.
Lassmann M, Biassoni L, Monsieurs M, Franzius C; EANM Dosimetry and Paediatrics Committees. The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1666-8. doi: 10.1007/s00259-008-0799-9. Epub 2008 Jun 24. Erratum in: Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2141
This card summarizes the views of the Paediatric and Dosimetry Committees of the EANM and reflects recommendations for which the EANM cannot be held responsible. The dosage recommendations should be taken in context of „good practice“ of nuclear medicine and do not substitute for national and international legal or regulatory provisions.